Outcomes for Hispanic patients undergoing open bypass in BEST-CLI
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.01.212 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Jesus G Ulloa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, UCLA, David Geffen School of Medicine, Los Angeles, CA. Electronic address: julloa@mednet.ucla.edu. Hauptthemen laut MEDLINE: Hispanic or Latino, Ischemia, Peripheral Arterial Disease, Saphenous Vein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: NHLBI NIH HHS, BD, Medtronic.
Abstract (Originalsprache)
OBJECTIVES: Hispanic patients have a higher prevalence of peripheral artery disease (PAD) risk factors, undergo revascularization at lower rates, and have higher rates of major amputation. This study compares outcomes after open surgical revascularization within the Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) Trial between Hispanic and non-Hispanic White patients. METHODS: In a secondary analysis of BEST-CLI, open surgical cohorts were combined (cohort 1, suitable single segment greater saphenous vein [n = 484]; cohort 2, lack of suitable single segment greater saphenous vein [n = 150]) and examined, by ethnicity, for the following 1-year outcomes: (1) above-ankle amputation, (2) major reintervention, (3) major adverse limb event (a composite of major amputation and major reintervention), and (4) survival. Cox regression models were constructed to determine the association between Hispanic ethnicity and selected endpoints after surgical bypass for patients enrolled in BEST-CLI. RESULTS: Of the 634 patients who underwent open surgical bypass, 528 (83.3%) were non-Hispanic White (White) and 106 (16.7%) were Hispanic. Compared with White patients, Hispanic patients were younger (64.6 ± 8.6 years vs 68.5 ± 9.6 years; P < .001), had a higher proportion of diabetes (91.5% vs 66.3%; P < .001), end-stage renal disease (15.1% vs 6.8%; P = .005), and were more often never smokers (44.3% vs 16.2%; P < .001). Preoperative ankle-brachial index was higher among Hispanic patients (0.7 ± 0.4 vs 0.5 ± 0.3; P < .001). After controlling for age, sex, diabetes, end-stage renal disease, smoking history, infrapopliteal disease, Wound Ischemia foot Infection stage, and previous lower extremity revascularization, Hispanic ethnicity was not significantly associated with major amputation (adjusted hazard ratio [aHR], 0.67; 95% confidence interval [CI], 0.30-1.48), major reintervention (aHR, 0.81; 95% CI, 0.35-1.87), major adverse limb event (aHR, 0.64; 95% CI, 0.34-1.21), or survival (aHR, 0.69; 95% CI, 0.42-1.13) 1 year after surgical bypass. CONCLUSIONS: Disparities in limb-related outcomes were not observed for Hispanic patients undergoing open revascularization in BEST-CLI. Future PAD clinical trials should capture metrics of access to care, and timeliness of care for assessing risk of disparate outcomes among PAD populations thought to be at higher risk based on epidemiological and retrospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, UCLA, David Geffen School of Medicine, Los Angeles, CA. Electronic address: julloa@mednet.ucla.edu.
- Surgical and Perioperative Care, Atlanta VA Health Care System, Decatur, GA; Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Emory University School of Medicine, Atlanta, GA.
- Division of Vascular Surgery, School of Medicine, University of North Carolina at Chapel, Chapel Hill, NC.
- Division of Vascular Surgery, UC San Diego Health, La Jolla, CA.
- Boston University, School of Public Health, Boston, MA.
- Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Förderung
- NHLBI NIH HHS
- BD
- Medtronic
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- Novo Nordisk Foundation
Zitieren
APA
Ulloa, J. G., Alabi, O., McGinigle, K., Lane, J., Doros, G., Menard, M., Moreira, C. C., Judelson, D. R., Farber, A., Conte, M. S., Rosenfeld, K., Hamouda, M., Kirksey, L., Strong, M. B., Malas, M., Kernodle, A., & Rowe, V. L. (2025). Outcomes for Hispanic patients undergoing open bypass in BEST-CLI. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.01.212
Vancouver
Ulloa JG, Alabi O, McGinigle K, Lane J, Doros G, Menard M, et al. Outcomes for Hispanic patients undergoing open bypass in BEST-CLI. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.01.212
BibTeX
@article{Ulloa2025,
author = {Ulloa, Jesus G and Alabi, Olamide and McGinigle, Katharine and Lane, John and Doros, Gheorghe and Menard, Matthew and Moreira, Carla C and Judelson, Deja R and Farber, Alik and Conte, Michael S and Rosenfeld, Kenneth and Hamouda, Mohammed and Kirksey, Lee and Strong, Michael B and Malas, Mahmoud and Kernodle, Amber and Rowe, Vincent L},
title = {Outcomes for Hispanic patients undergoing open bypass in BEST-CLI},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.01.212}
}
EUVIMED